Cancers, Vol. 12, Pages 2752: Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial

Conclusions: In this study, approximately 1 out of 4 refractory CRC patients who were judged to have a life expectancy >12 weeks actually died within 12 weeks. Baseline assessment of WB-MATV, cfDNA, CTCs and CEA, but not early change evaluation of the same, may help to refine patient prognostication and guide management decisions.

Source: Cancers - September 23, 2020 Category: Cancer & Oncology Authors: Silvia Camera Tugba Akin Telli Erwin Woff Caroline Vandeputte Pashalina Kehagias Thomas Guiot Gabriela Critchi Yacine Wissam Giacomo Bregni Elena Trevisi Andrea Pretta Chiara Senti Sophia Leduc Paraskevas Gkolfakis Fr édéric Hoerner Fran çoise Rothé F Tags: Article Source Type: research